Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma

Published:2023-02-03 Issue:3 Volume:49 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Sun Liwei¹,Wang Hankang¹,Liu Qian²,Meng Fanguang¹,Zhang Jinliang¹,Li Xiaodong¹,Chang Shulin¹,Li Guijie¹,Chen Feng¹

Affiliation:

1. Department of Radiology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan, Shandong 250014, P.R. China

2. Department of Radiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference58 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A systematic review and network meta-analysis of randomized clinical trials;Liu;Front Oncol,2021

3. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): A randomised placebo-controlled, double-blind, phase 3 trial;Meyer;Lancet Gastroenterol Hepatol,2017

4. Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation;Sun;Redox Biol,2021

5. Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis;Zhang;Toxicol Mech Methods,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAMPTOTHECIN SUPPRESSES CELL PROLIFERATION AND MIGRATION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA BY BLOCKING RAB27A-MEDIATED PHOSPHATIDYLINOSITOL 3 KINASE (PI3K)/PROTEIN KINASE B (AKT) PATHWAY;J PHYSIOL PHARMACOL;2024

2. Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma;Scientific Reports;2024-03-26

3. Low-dose apatinib and CPT synergistically optimize the tumor microenvironment and enhance the antitumor effects of PD-1 inhibitors in hepatocellular carcinoma;2023-11-20

4. Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy;European Journal of Pharmacology;2023-09